Assignee
KYVERNA THERAPEUTICS INC
US·2 granted patents·12 pending applications·1 citations·filing 2021–2024
Top patents by PatentIndex Score
14 records- 0181US11446357B2Method for treating disease using FOXP3+CD4+ T cellsKYVERNA THERAPEUTICS INC·Filed 2021·Granted Sep 20, 2022·1 cites·15 claims
- 0264US2023104151A1A method for treating disease using foxp3+cd4+ t cellsKYVERNA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0362US11879003B2Methods for increasing T-cell functionKYVERNA THERAPEUTICS INC·Filed 2022·Granted Jan 23, 2024·0 cites·24 claims
- 0461US2023330141A1Methods of producing t regulatory cells, methods of transducing t cells, and uses of the sameKYVERNA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0560US2022169687A1Method for treating disease using foxp3+cd4+ t cellsKYVERNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0660US2024158459A1Methods for increasing t-cell functionKYVERNA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0758US2025032614A1Methods for treating stiff person syndrome and myasthenia gravis using anti-cd19 car-t cell therapeuticsKYVERNA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0858US2024424100A1Methods of treating lupus nephritis using anti-cd19 car-t cell therapiesKYVERNA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0957US2023210900A1Methods for treating autoimmune diseasesKYVERNA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1057US2024261405A1Methods and compositions for treating autoimmune diseaseKYVERNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1155US2022031751A1Methods of producing t regulatory cells, methods of transducing t cells, and uses of the sameKYVERNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1255US2023399375A1Methods and compositions for treating autoimmune diseaseKYVERNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1350US2023056336A1Methods and compositions for treating disease using targeted foxp3+cd4+ t cells and cellular suicide agentsKYVERNA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1448US2022110975A1Method for treating disease using foxp3+cd4+ t cellsKYVERNA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KYVERNA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →